Project Grant R42CA295106
Award Date
9/20/24
Completion Date
8/31/26
Dollars Obligated
$1.9M
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $328,822 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Implenomics Llcs, a minority-owned, women-owned small business located in Marblehead, Massachusetts. The grant, effective September 20, 2024 through August 31, 2026, will fund the development and pilot testing of the Integrated Cancer Awareness Network (ICAN), an innovative mHealth platform. ICAN will provide cancer risk, symptom, and screening education to...
The National Cancer Institute (NCI) awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh to conduct a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES." The goal of the 5-year project is to evaluate the effectiveness and implementation of CARES, an integrated EHR-based screening and stepped collaborative care intervention, in improving patient-centered outcomes for over...
This National Cancer Institute (NCI) Project Grant award under CFDA 93.393 (Cancer Cause and Prevention Research) will provide $1,500,000 to the University of Rochester over 5 years starting September 2024. The grant will fund research to elucidate how the structural, functional, and relational characteristics of social networks of older adults with advanced cancer influence their engagement in key end-of-life health behaviors, including initiating serious illness conversations, completing...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
The National Cancer Institute (NCI) awarded a $3,998,962 Cooperative Agreement titled "Cancer Cause and Prevention Research" (CFDA 93.393) to Northwestern University to establish the "Advancing Cancer Control Equity Research Through Transformative Solutions in Patient Navigation (ACCERT PN) Center." The Center will develop community-engaged interventions, measures, and methods for addressing structural racism and social determinants of health to mitigate cancer health...
This federal Project Grant award, titled "Designing for Sustainability: Co-Designing and Testing the Efficacy of a Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety for Rural Older Cancer Survivors", is funded by the National Institute of Nursing Research (NINR) under CFDA 93.361 - Nursing Research. The key products and services to be delivered through this $1,655,744 grant, awarded on Sep 23, 2024, are: Adapting and enhancing a web-based toolkit called...
The National Cancer Institute (NCI) awarded a $578,467 Project Grant (CFDA 93.395 - Cancer Treatment Research) to Duke University to conduct a randomized controlled trial evaluating the efficacy of a telehealth-delivered psychosocial intervention called ENGAGE. The goal of the ENGAGE intervention is to decrease symptom interference (e.g., pain, fatigue, distress) and improve quality of life for patients with advanced cancer receiving care in medically underserved areas. The 5-year project will...
The National Cancer Institute (NCI) awarded a $156,616 Project Grant under CFDA 93.393 "Cancer Cause and Prevention Research" to The Feinstein Institutes for Medical Research, a non-profit research organization. The purpose of this 2-year grant is to develop and conduct a preliminary psychometric evaluation of the Social Isolation Risk Scale (SIRS), a screening tool to identify head and neck cancer survivors at risk for social isolation. Key activities include: Developing an initial...
The National Cancer Institute (NCI) awarded a $256,487 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Sloan-Kettering Institute for Cancer Research in New York, NY. The purpose of this 5-year grant is to develop multimodal predictive models that integrate real-world data from circulating tumor DNA (ctDNA) sequencing, radiomics, tumor registries, and tissue genomics to improve risk stratification and clinical management of non-small cell lung cancer (NSCLC). The...